Cargando…

Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020

BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Migisha, Richard, Kwesiga, Benon, Mirembe, Bernadette Basuta, Amanya, Geofrey, Kabwama, Steven N., Kadobera, Daniel, Bulage, Lilian, Nsereko, Godfrey, Wadunde, Ignatius, Tindyebwa, Tonny, Lubwama, Bernard, Kagirita, Atek A., Kayiwa, John T., Lutwama, Julius J., Boore, Amy L., Harris, Julie R., Bosa, Henry Kyobe, Ario, Alex Riolexus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686950/
https://www.ncbi.nlm.nih.gov/pubmed/33239041
http://dx.doi.org/10.1186/s12992-020-00643-7
_version_ 1783613431180427264
author Migisha, Richard
Kwesiga, Benon
Mirembe, Bernadette Basuta
Amanya, Geofrey
Kabwama, Steven N.
Kadobera, Daniel
Bulage, Lilian
Nsereko, Godfrey
Wadunde, Ignatius
Tindyebwa, Tonny
Lubwama, Bernard
Kagirita, Atek A.
Kayiwa, John T.
Lutwama, Julius J.
Boore, Amy L.
Harris, Julie R.
Bosa, Henry Kyobe
Ario, Alex Riolexus
author_facet Migisha, Richard
Kwesiga, Benon
Mirembe, Bernadette Basuta
Amanya, Geofrey
Kabwama, Steven N.
Kadobera, Daniel
Bulage, Lilian
Nsereko, Godfrey
Wadunde, Ignatius
Tindyebwa, Tonny
Lubwama, Bernard
Kagirita, Atek A.
Kayiwa, John T.
Lutwama, Julius J.
Boore, Amy L.
Harris, Julie R.
Bosa, Henry Kyobe
Ario, Alex Riolexus
author_sort Migisha, Richard
collection PubMed
description BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported its first SARS-CoV-2 infection in a symptomatic traveler from Dubai. By April 12, 2020, 54 cases and 1257 contacts were identified. We describe the epidemiological, clinical, and transmission characteristics of these cases. METHODS: A confirmed case was laboratory-confirmed SARS-CoV-2 infection during March 21–April 12, 2020 in a resident of or traveler to Uganda. We reviewed case-person files and interviewed case-persons at isolation centers. We identified infected contacts from contact tracing records. RESULTS: Mean case-person age was 35 (±16) years; 34 (63%) were male. Forty-five (83%) had recently traveled internationally (‘imported cases’), five (9.3%) were known contacts of travelers, and four (7.4%) were community cases. Of the 45 imported cases, only one (2.2%) was symptomatic at entry. Among all case-persons, 29 (54%) were symptomatic at testing and five (9.3%) were pre-symptomatic. Among the 34 (63%) case-persons who were ever symptomatic, all had mild disease: 16 (47%) had fever, 13 (38%) reported headache, and 10 (29%) reported cough. Fifteen (28%) case-persons had underlying conditions, including three persons with HIV. An average of 31 contacts (range, 4–130) were identified per case-person. Five (10%) case-persons, all symptomatic, infected one contact each. CONCLUSION: The first 54 case-persons with SARS-CoV-2 infection in Uganda primarily comprised incoming air travelers with asymptomatic or mild disease. Disease would likely not have been detected in these persons without the targeted testing interventions implemented in Uganda. Transmission was low among symptomatic persons and nonexistent from asymptomatic persons. Routine, systematic screening of travelers and at-risk persons, and thorough contact tracing will be needed for Uganda to maintain epidemic control.
format Online
Article
Text
id pubmed-7686950
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76869502020-11-25 Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020 Migisha, Richard Kwesiga, Benon Mirembe, Bernadette Basuta Amanya, Geofrey Kabwama, Steven N. Kadobera, Daniel Bulage, Lilian Nsereko, Godfrey Wadunde, Ignatius Tindyebwa, Tonny Lubwama, Bernard Kagirita, Atek A. Kayiwa, John T. Lutwama, Julius J. Boore, Amy L. Harris, Julie R. Bosa, Henry Kyobe Ario, Alex Riolexus Global Health Research BACKGROUND: On March 13, 2020, Uganda instituted COVID-19 symptom screening at its international airport, isolation and SARS-CoV-2 testing for symptomatic persons, and mandatory 14-day quarantine and testing of persons traveling through or from high-risk countries. On March 21, 2020, Uganda reported its first SARS-CoV-2 infection in a symptomatic traveler from Dubai. By April 12, 2020, 54 cases and 1257 contacts were identified. We describe the epidemiological, clinical, and transmission characteristics of these cases. METHODS: A confirmed case was laboratory-confirmed SARS-CoV-2 infection during March 21–April 12, 2020 in a resident of or traveler to Uganda. We reviewed case-person files and interviewed case-persons at isolation centers. We identified infected contacts from contact tracing records. RESULTS: Mean case-person age was 35 (±16) years; 34 (63%) were male. Forty-five (83%) had recently traveled internationally (‘imported cases’), five (9.3%) were known contacts of travelers, and four (7.4%) were community cases. Of the 45 imported cases, only one (2.2%) was symptomatic at entry. Among all case-persons, 29 (54%) were symptomatic at testing and five (9.3%) were pre-symptomatic. Among the 34 (63%) case-persons who were ever symptomatic, all had mild disease: 16 (47%) had fever, 13 (38%) reported headache, and 10 (29%) reported cough. Fifteen (28%) case-persons had underlying conditions, including three persons with HIV. An average of 31 contacts (range, 4–130) were identified per case-person. Five (10%) case-persons, all symptomatic, infected one contact each. CONCLUSION: The first 54 case-persons with SARS-CoV-2 infection in Uganda primarily comprised incoming air travelers with asymptomatic or mild disease. Disease would likely not have been detected in these persons without the targeted testing interventions implemented in Uganda. Transmission was low among symptomatic persons and nonexistent from asymptomatic persons. Routine, systematic screening of travelers and at-risk persons, and thorough contact tracing will be needed for Uganda to maintain epidemic control. BioMed Central 2020-11-25 /pmc/articles/PMC7686950/ /pubmed/33239041 http://dx.doi.org/10.1186/s12992-020-00643-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Migisha, Richard
Kwesiga, Benon
Mirembe, Bernadette Basuta
Amanya, Geofrey
Kabwama, Steven N.
Kadobera, Daniel
Bulage, Lilian
Nsereko, Godfrey
Wadunde, Ignatius
Tindyebwa, Tonny
Lubwama, Bernard
Kagirita, Atek A.
Kayiwa, John T.
Lutwama, Julius J.
Boore, Amy L.
Harris, Julie R.
Bosa, Henry Kyobe
Ario, Alex Riolexus
Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title_full Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title_fullStr Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title_full_unstemmed Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title_short Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches – March-April 2020
title_sort early cases of sars-cov-2 infection in uganda: epidemiology and lessons learned from risk-based testing approaches – march-april 2020
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686950/
https://www.ncbi.nlm.nih.gov/pubmed/33239041
http://dx.doi.org/10.1186/s12992-020-00643-7
work_keys_str_mv AT migisharichard earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT kwesigabenon earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT mirembebernadettebasuta earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT amanyageofrey earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT kabwamastevenn earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT kadoberadaniel earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT bulagelilian earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT nserekogodfrey earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT wadundeignatius earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT tindyebwatonny earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT lubwamabernard earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT kagiritaateka earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT kayiwajohnt earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT lutwamajuliusj earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT booreamyl earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT harrisjulier earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT bosahenrykyobe earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020
AT arioalexriolexus earlycasesofsarscov2infectioninugandaepidemiologyandlessonslearnedfromriskbasedtestingapproachesmarchapril2020